- Home
- IVCB vs PYXS Comparison
IVCB vs PYXS Comparison
Compare IVCB & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVCB
- PYXS
- Stock Information
- Founded
- IVCB 2021
- PYXS 2018
- Country
- IVCB Cayman Islands
- PYXS United States
- Employees
- IVCB N/A
- PYXS N/A
- Industry
- IVCB Blank Checks
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- IVCB Finance
- PYXS Health Care
- Exchange
- IVCB Nasdaq
- PYXS Nasdaq
- Market Cap
- IVCB 212.7M
- PYXS 210.4M
- IPO Year
- IVCB 2021
- PYXS 2021
- Fundamental
- Price
- IVCB $11.80
- PYXS $3.23
- Analyst Decision
- IVCB
- PYXS Strong Buy
- Analyst Count
- IVCB 0
- PYXS 6
- Target Price
- IVCB N/A
- PYXS $9.00
- AVG Volume (30 Days)
- IVCB 41.7K
- PYXS 456.9K
- Earning Date
- IVCB 01-01-0001
- PYXS 11-05-2024
- Dividend Yield
- IVCB N/A
- PYXS N/A
- EPS Growth
- IVCB N/A
- PYXS N/A
- EPS
- IVCB 0.22
- PYXS N/A
- Revenue
- IVCB N/A
- PYXS $16,146,000.00
- Revenue This Year
- IVCB N/A
- PYXS N/A
- Revenue Next Year
- IVCB N/A
- PYXS N/A
- P/E Ratio
- IVCB $52.92
- PYXS N/A
- Revenue Growth
- IVCB N/A
- PYXS N/A
- 52 Week Low
- IVCB $10.91
- PYXS $1.35
- 52 Week High
- IVCB $12.16
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- IVCB 68.30
- PYXS 40.94
- Support Level
- IVCB $11.73
- PYXS $3.11
- Resistance Level
- IVCB $11.85
- PYXS $3.42
- Average True Range (ATR)
- IVCB 0.02
- PYXS 0.16
- MACD
- IVCB -0.01
- PYXS -0.02
- Stochastic Oscillator
- IVCB 60.00
- PYXS 32.86
About IVCB Investcorp Europe Acquisition Corp I
Investcorp Europe Acquisition Corp I is a blank check company.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.